Lv4
460 积分 2023-12-21 加入
Phase 1 Dose-Escalation Study of [ 225 Ac]Ac-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer: An Analysis of Safety, Tolerability, and Dosimetry
7天前
已完结
Phase 1 Dose-Escalation Study of [ 225 Ac]Ac-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer: An Analysis of Safety, Tolerability, and Dosimetry
7天前
已完结
Head-to-Head Comparison of 68Ga-PSMA-11 with 68Ga-P137 in Patients with Suspected Prostate Cancer
7天前
已完结
Head-to-head comparison of [68 Ga]Ga-P16-093 and [68 Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients
7天前
已完结
First-in-Human PET Imaging of Prostate Cancer Using [ 68 Ga]Ga-AZ-093 and Its Nitroimidazole-Conjugated Derivative [ 68 Ga]Ga-AZ-NI-093
7天前
已完结
Phase 1 Dose-Escalation Study of [ 225 Ac]Ac-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer: An Analysis of Safety, Tolerability, and Dosimetry
21天前
已完结
Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [ 68 Ga]Ga-OncoACP3-DOTA PET in Patients with Prostate Cancer
22天前
已完结
Discovery of high-affinity ligands for prostatic acid phosphatase via DNA-encoded library screening enables targeted cancer therapy
22天前
已完结
Prostatic acid phosphatase: a rediscovered target in prostate cancer
22天前
已完结
Targeting Prostatic Acid Phosphatase in Prostate Cancer: Roadmap on How To Venture Above and Beyond Prostate-specific Membrane Antigen with ACP3 Theranostics
22天前
已完结
皖公网安备34019202002308
